Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1687
https://www.valueinhealthjournal.com/article/S1098-3015(14)03617-1/fulltext
Title : Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03617-1&doi=10.1016/j.jval.2014.08.1687
First page : A531
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1161
Categories :
Tags :
Regions :
ViH Article Tags :